Literature DB >> 34962226

Comparison of conventional and actuarial neuropsychological criteria for mild cognitive impairment in a clinical setting.

Stephanie Fountain-Zaragoza1,2, Sarah Ellen Braun3, Michael David Horner1,2, Andreana Benitez4.   

Abstract

INTRODUCTION: Evidence-based practice in neuropsychology involves the use of validated tests, cutoff scores, and interpretive algorithms to identify clinically significant cognitive deficits. Recently, actuarial neuropsychological criteria (ANP) for identifying mild cognitive impairment were developed, demonstrating improved criterion validity and temporal stability compared to conventional criteria (CNP). However, benefits of the ANP criteria have not been investigated in non-research, clinical settings with varied etiologies, severities, and comorbidities. This study compared the utility of CNP and ANP criteria using data from a memory disorders clinic.
METHOD: Data from 500 non-demented older adults evaluated in a Veterans Affairs Medical Center memory disorders clinic were retrospectively analyzed. We applied CNP and ANP criteria to the Repeatable Battery for the Assessment of Neuropsychological Status, compared outcomes to consensus clinical diagnoses, and conducted cluster analyses of scores from each group.
RESULTS: The majority (72%) of patients met both the CNP and ANP criteria and both approaches were susceptible to confounding factors such as invalid test data and mood disturbance. However, the CNP approach mislabeled impairment in more patients with non-cognitive disorders and intact cognition. Comparatively, the ANP approach misdiagnosed patients with depression at a third of the rate and those with no diagnosis at nearly half the rate of CNP. Cluster analyses revealed groups with: 1) minimal impairment, 2) amnestic impairment, and 3) multi-domain impairment. The ANP approach yielded subgroups with more distinct neuropsychological profiles.
CONCLUSIONS: We replicated previous findings that the CNP approach is over-inclusive, particularly for those determined to have no cognitive disorder by a consensus team. The ANP approach yielded fewer false positives and better diagnostic specificity than the CNP. Despite clear benefits of the ANP vs. CNP, there was substantial overlap in their performance in this heterogeneous sample. These findings highlight the critical role of clinical interpretation when wielding these empirically-derived tools.

Entities:  

Keywords:  Diagnostic criteria; cluster analysis; cognition; evidence-based practice; memory disorders; neuropsychology

Mesh:

Year:  2021        PMID: 34962226      PMCID: PMC8881966          DOI: 10.1080/13803395.2021.2007857

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  40 in total

1.  Predicting change with the RBANS in a community dwelling elderly sample.

Authors:  Kevin Duff; Mike R Schoenberg; Doyle Patton; James Mold; James G Scott; Russell L Adams
Journal:  J Int Neuropsychol Soc       Date:  2004-10       Impact factor: 2.892

Review 2.  Mild cognitive impairment as a clinical entity and treatment target.

Authors:  Ronald C Petersen; John C Morris
Journal:  Arch Neurol       Date:  2005-07

3.  A comparison of four embedded validity indices for the RBANS in a memory disorders clinic.

Authors:  Daniel Paulson; Michael David Horner; David Bachman
Journal:  Arch Clin Neuropsychol       Date:  2015-03-16       Impact factor: 2.813

4.  Stability in Test-Usage Practices of Clinical Neuropsychologists in the United States and Canada Over a 10-Year Period: A Follow-Up Survey of INS and NAN Members.

Authors:  Laura A Rabin; Emily Paolillo; William B Barr
Journal:  Arch Clin Neuropsychol       Date:  2016-03-16       Impact factor: 2.813

Review 5.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

6.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease.

Authors:  Stella Karantzoulis; Julia Novitski; Michael Gold; Christopher Randolph
Journal:  Arch Clin Neuropsychol       Date:  2013-07-17       Impact factor: 2.813

7.  Quantification of five neuropsychological approaches to defining mild cognitive impairment.

Authors:  Amy J Jak; Mark W Bondi; Lisa Delano-Wood; Christina Wierenga; Jody Corey-Bloom; David P Salmon; Dean C Delis
Journal:  Am J Geriatr Psychiatry       Date:  2009-05       Impact factor: 4.105

8.  Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.

Authors:  Katherine J Bangen; Alexandra L Clark; Madeline Werhane; Emily C Edmonds; Daniel A Nation; Nicole Evangelista; David J Libon; Mark W Bondi; Lisa Delano-Wood
Journal:  J Alzheimers Dis       Date:  2016-03-29       Impact factor: 4.472

9.  Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: sensitivity, specificity, and positive and negative predictive powers.

Authors:  Kevin Duff; Joy D Humphreys Clark; Sid E O'Bryant; James W Mold; Randolph B Schiffer; Patricia B Sutker
Journal:  Arch Clin Neuropsychol       Date:  2008-07-17       Impact factor: 2.813

10.  Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old.

Authors:  Christina G Wong; Kelsey R Thomas; Emily C Edmonds; Alexandra J Weigand; Katherine J Bangen; Joel S Eppig; Amy J Jak; Sherral A Devine; Lisa Delano-Wood; David J Libon; Steven D Edland; Rhoda Au; Mark W Bondi
Journal:  Dement Geriatr Cogn Disord       Date:  2018-11-02       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.